SynGen Gets $5M For Stem Cell Harvesting

Sacramento-based SynGen, which is developing stem cell harvesting systems for the regenerative medicine market, has raised $5M in a Series A funding. The round came from Bay City Capital. According to the firms, Bay City Capital will add two representatives to SynGen's board as part of the funding. SynGen is headed by Phil Coelho, and is developing a medical device to automate stem cells from umbilical cord blood, bone marrow, and adipose tissue.